Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04320862 · ClinicalTrials.gov registry record

COVID-19 Pandemic Response Network

A clinical trial, sponsored by Duke University.

Completed
Registry status
9,207
Enrollment target

NCT04320862 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 9,207 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04320862 has completed, sponsored by Duke University.

COMPLETED
Registry status
9,207 participants
Enrollment target

Study Summary

Coronavirus Disease 19 (COVID-19) represents an unprecedented challenge to the operations and population health management efforts of health care systems around the world. The "Pandemic Research Network (PRN): Duke Community Health Watch" study leverages technology, clinical research, epidemiology, telemedicine, and population health management capabilities to understand how to safely COVID-19. The target population is individuals in the Duke Health region as well as individuals beyond the Duke Health region who have flu-like symptoms, a viral test order for COVID-19, confirmed COVID-19, or concern for exposure to COVID-19. A subgroup of particular interest within the target population is health care workers (HCW) and families of HCW. Community members will enroll in the study electronically and for 28 days will be reminded via email or SMS to submit signs and symptoms related to COVID-19. Participants who report symptoms will be provided information about COVID-19 testing (if needed) and established mechanisms to seek care within Duke Health. Instructions for telemedicine and in-person visits, which is available publicly at https://www.dukehealth.org/covid-19-update, will be presented to participants. Participants who are unable to report symptoms independently may be contacted via telephone by Population Health Management Office (PHMO) or Clinical Events Classification (CEC) team members. Data collected through the "Pandemic Response Network (PRN): Duke Community Health Watch" study will be used for three objectives. * First, to characterize the epidemiological features of COVID-19. Specifically, we will have a high-risk subgroup of HCW and families of HCW that we enroll. * Second, to develop models that predict deterioration and the need for inpatient care, intensive care, and mechanical ventilation. * Third, to develop forecast models to estimate the volume of inpatient and outpatient resources needed to manage a COVID-19 population. The primary risk to study

Trial Details

FieldValue
Enrollment Target 9,207 participants
Start Date 2020-04-03
Est. Completion 2021-04-30

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT04320862

The ClinicalTrials.gov registry entry for NCT04320862 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 9,207 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT04320862 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04320862 about?

NCT04320862 is a clinical study titled "COVID-19 Pandemic Response Network". Coronavirus Disease 19 (COVID-19) represents an unprecedented challenge to the operations and population health management efforts of health care systems around the world. The "Pandemic Research Network (PRN): Duke Community Health Watch" study leverages technology, clinical research, epidemiology, ...

What is the current status of trial NCT04320862?

This trial is currently completed. The enrollment target is 9,207 participants. The study started on 2020-04-03. Estimated completion is 2021-04-30.

Who is sponsoring clinical trial NCT04320862?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.